Posted On: 08/13/2014 12:26:46 PM
Post# of 89114
$ARWR Headlines
Nasdaq breaks out, S&P 500 takes flight 11:37 a.m. June 6, 2014 - Michael Ashbaugh
Despite skepticism, market technicals remain bullish 12:53 p.m. March 11, 2014 - Michael Ashbaugh
Despite skepticism, market technicals remain bullish 12:40 p.m. March 11, 2014 - Michael Ashbaugh
U.S. benchmarks rattle the cage on major resistance 1:16 p.m. Feb. 7, 2014 - Michael Ashbaugh
Beware the dead-cat bounce 2:24 p.m. Jan. 28, 2014 - Michael Ashbaugh
Beware the dead-cat bounce 2:06 p.m. Jan. 28, 2014 - Michael Ashbaugh
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
A 6-pack of hedge fund moves to take note of 12:08 p.m. Oct. 21, 2013 - Insider Monkey
Six stocks poised to move higher 3:23 p.m. Oct. 2, 2013 - The Trading Deck
3 longs and 3 shorts to watch 1:00 p.m. Sept. 26, 2013 - The Trading Deck
Arrowhead reports positive data on hep B drug 2:10 p.m. Feb. 26, 2013 - MarketWatch.com
Six companies unveil share, unit offerings 8:45 a.m. Dec. 7, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:12 p.m. Aug. 13, 2012 - MarketWatch
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day 3:06 a.m. Today - Zacks.com
Arrowhead's (ARWR) CEO Dr. Christopher Anzalone on Q3 2014 Results - Earnings Call Transcript 10:29 p.m. Aug. 12, 2014 - Seeking Alpha
Arrowhead Discloses First Human Hepatitis B Therapy Results 5:11 p.m. Aug. 12, 2014 - TheStreet.com
Arrowhead Research (ARWR) Q3 2014 Results - Earnings Call Webcast 4:25 p.m. Aug. 12, 2014 - Seeking Alpha
10-Q: ARROWHEAD RESEARCH CORP 4:03 p.m. Aug. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Arrowhead's Hep B Phase 2a Topline Data Imminent - 'Transformational' Potential 12:27 p.m. Aug. 12, 2014 - Seeking Alpha
Has The Tekmira Pharmaceuticals Ebola Trade Run Its Course? 11:54 a.m. Aug. 5, 2014 - Seeking Alpha
Today's Dead Cat Bounce Stock Is Arrowhead Research (ARWR) 9:55 a.m. Aug. 4, 2014 - TheStreet.com
Biotech Stock Mailbag: Arrowhead, Catalyst Pharma 8:06 a.m. Aug. 1, 2014 - TheStreet.com
Trade-Ideas: Arrowhead Research (ARWR) Is Today's "Perilous Reversal" Stock 9:46 a.m. July 31, 2014 - TheStreet.com
Morning Market Movers 8:42 a.m. July 29, 2014 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:13 a.m. July 29, 2014 - benzinga.com
'Fast Money' Recap: Playing China Through U.S. Stocks 5:00 a.m. July 29, 2014 - TheStreet.com
Alnylam And Benitec 8:16 a.m. July 25, 2014 - Seeking Alpha
Arrowhead Research (ARWR) Highlighted As Today's Perilous Reversal Stock 1:59 p.m. July 24, 2014 - TheStreet.com
14 Insanely Important Biotech/Drug Trading Catalysts for the Rest of 2014 11:54 a.m. July 10, 2014 - TheStreet.com
Arrowhead Research (ARWR) Highlighted As Today's Perilous Reversal Stock 9:46 a.m. July 10, 2014 - TheStreet.com
Arrowhead Research Up Over 6% Following CNBC Comments 10:51 a.m. July 9, 2014 - benzinga.com
Trade-Ideas: Arrowhead Research (ARWR) Is Today's "Dead Cat Bounce" Stock 9:47 a.m. July 9, 2014 - TheStreet.com
'Fast Money' Recap: Waiting for the Dust to Settle 5:00 a.m. July 9, 2014 - TheStreet.com
Arrowhead Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on ARC-520 5:02 p.m. Aug. 12, 2014 - BusinessWire - BZX
Technical Data on Biotech Stocks -- Arrowhead Research, Celldex Therapeutics, Synthetic Biologics, StemCells, and Sarepta Therapeutics 8:50 a.m. Aug. 4, 2014 - PR Newswire - PRF
Arrowhead to Report Fiscal 2014 Third Quarter Financial Results 4:08 p.m. July 31, 2014 - BusinessWire - BZX
SEC Filings, Positive Trial Results, Technical Updates, and sNDA Updates - Analyst Notes on Questcor, Exelixis, InterMune, Progenics and Arrowhead 8:40 a.m. July 18, 2014 - PR Newswire - PRF
Technical Updates, License Agreements, and Acquisitions - Analyst Notes on Incyte, BioMarin, Arrowhead, Ligand and Techne 5:50 a.m. July 8, 2014 - PR Newswire - PRF
Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma 7:50 a.m. June 27, 2014 - PR Newswire - PRF
Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics 5:00 a.m. June 27, 2014 - PR Newswire - PRF
Upcoming Conferences, Tentative Meeting Schedules, Analyst Day, Public Offerings, and Data Presentations - Analyst Notes on Incyte, NPS Pharmaceuticals, Arrowhead, Novavax and Chelsea Therapeutics 5:00 a.m. June 17, 2014 - PR Newswire - PRF
Arrowhead Research Set to Join Russell 3000 Index 7:30 a.m. June 16, 2014 - BusinessWire - BZX
Arrowhead Issues a Statement on Intellectual Property Protection for ARC-520 5:41 p.m. June 13, 2014 - BusinessWire - BZX
Arrowhead to Host Analyst Day to Discuss New Rare Liver Disease Candidate 4:05 p.m. June 11, 2014 - BusinessWire - BZX
Arrowhead to Present at Upcoming Investor Conferences 4:05 p.m. June 10, 2014 - BusinessWire - BZX
Strategic Acquisitions, Clinical Data Presentations, Research Grants, and Technical Updates - Analyst Notes on Acadia, Opko Health, Arrowhead Research, Agios Pharmaceuticals and Sangamo Biosciences 5:10 a.m. June 6, 2014 - PR Newswire - PRF
Arrowhead to Present at the Jefferies 2014 Global Healthcare Conference 7:31 a.m. May 29, 2014 - BusinessWire - BZX
Top Gainers Pre-Market Notes -- Research on Millennial Media, Demandware, Arrowhead Research, and KEYW Holding 9:12 a.m. May 20, 2014 - PR Newswire - PRF
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Arrowhead to Present at Upcoming Scientific Conferences 4:04 p.m. May 6, 2014 - BusinessWire - BZX
Arrowhead Reports Fiscal 2014 Second Quarter Financial Results 4:03 p.m. May 6, 2014 - BusinessWire - BZX
Arrowhead to Present at Deutsche Bank 39th Annual Health Care Conference 7:32 a.m. May 1, 2014 - BusinessWire - BZX
Arrowhead to Report Fiscal 2014 Second Quarter Financial Results 4:08 p.m. April 29, 2014 - BusinessWire - BZX
Nasdaq breaks out, S&P 500 takes flight 11:37 a.m. June 6, 2014 - Michael Ashbaugh
Despite skepticism, market technicals remain bullish 12:53 p.m. March 11, 2014 - Michael Ashbaugh
Despite skepticism, market technicals remain bullish 12:40 p.m. March 11, 2014 - Michael Ashbaugh
U.S. benchmarks rattle the cage on major resistance 1:16 p.m. Feb. 7, 2014 - Michael Ashbaugh
Beware the dead-cat bounce 2:24 p.m. Jan. 28, 2014 - Michael Ashbaugh
Beware the dead-cat bounce 2:06 p.m. Jan. 28, 2014 - Michael Ashbaugh
5 charts to watch 4:52 p.m. Jan. 15, 2014 - The Trading Deck
A 6-pack of hedge fund moves to take note of 12:08 p.m. Oct. 21, 2013 - Insider Monkey
Six stocks poised to move higher 3:23 p.m. Oct. 2, 2013 - The Trading Deck
3 longs and 3 shorts to watch 1:00 p.m. Sept. 26, 2013 - The Trading Deck
Arrowhead reports positive data on hep B drug 2:10 p.m. Feb. 26, 2013 - MarketWatch.com
Six companies unveil share, unit offerings 8:45 a.m. Dec. 7, 2012 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:12 p.m. Aug. 13, 2012 - MarketWatch
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day 3:06 a.m. Today - Zacks.com
Arrowhead's (ARWR) CEO Dr. Christopher Anzalone on Q3 2014 Results - Earnings Call Transcript 10:29 p.m. Aug. 12, 2014 - Seeking Alpha
Arrowhead Discloses First Human Hepatitis B Therapy Results 5:11 p.m. Aug. 12, 2014 - TheStreet.com
Arrowhead Research (ARWR) Q3 2014 Results - Earnings Call Webcast 4:25 p.m. Aug. 12, 2014 - Seeking Alpha
10-Q: ARROWHEAD RESEARCH CORP 4:03 p.m. Aug. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Arrowhead's Hep B Phase 2a Topline Data Imminent - 'Transformational' Potential 12:27 p.m. Aug. 12, 2014 - Seeking Alpha
Has The Tekmira Pharmaceuticals Ebola Trade Run Its Course? 11:54 a.m. Aug. 5, 2014 - Seeking Alpha
Today's Dead Cat Bounce Stock Is Arrowhead Research (ARWR) 9:55 a.m. Aug. 4, 2014 - TheStreet.com
Biotech Stock Mailbag: Arrowhead, Catalyst Pharma 8:06 a.m. Aug. 1, 2014 - TheStreet.com
Trade-Ideas: Arrowhead Research (ARWR) Is Today's "Perilous Reversal" Stock 9:46 a.m. July 31, 2014 - TheStreet.com
Morning Market Movers 8:42 a.m. July 29, 2014 - benzinga.com
Benzinga's Top #PreMarket Gainers 7:13 a.m. July 29, 2014 - benzinga.com
'Fast Money' Recap: Playing China Through U.S. Stocks 5:00 a.m. July 29, 2014 - TheStreet.com
Alnylam And Benitec 8:16 a.m. July 25, 2014 - Seeking Alpha
Arrowhead Research (ARWR) Highlighted As Today's Perilous Reversal Stock 1:59 p.m. July 24, 2014 - TheStreet.com
14 Insanely Important Biotech/Drug Trading Catalysts for the Rest of 2014 11:54 a.m. July 10, 2014 - TheStreet.com
Arrowhead Research (ARWR) Highlighted As Today's Perilous Reversal Stock 9:46 a.m. July 10, 2014 - TheStreet.com
Arrowhead Research Up Over 6% Following CNBC Comments 10:51 a.m. July 9, 2014 - benzinga.com
Trade-Ideas: Arrowhead Research (ARWR) Is Today's "Dead Cat Bounce" Stock 9:47 a.m. July 9, 2014 - TheStreet.com
'Fast Money' Recap: Waiting for the Dust to Settle 5:00 a.m. July 9, 2014 - TheStreet.com
Arrowhead Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on ARC-520 5:02 p.m. Aug. 12, 2014 - BusinessWire - BZX
Technical Data on Biotech Stocks -- Arrowhead Research, Celldex Therapeutics, Synthetic Biologics, StemCells, and Sarepta Therapeutics 8:50 a.m. Aug. 4, 2014 - PR Newswire - PRF
Arrowhead to Report Fiscal 2014 Third Quarter Financial Results 4:08 p.m. July 31, 2014 - BusinessWire - BZX
SEC Filings, Positive Trial Results, Technical Updates, and sNDA Updates - Analyst Notes on Questcor, Exelixis, InterMune, Progenics and Arrowhead 8:40 a.m. July 18, 2014 - PR Newswire - PRF
Technical Updates, License Agreements, and Acquisitions - Analyst Notes on Incyte, BioMarin, Arrowhead, Ligand and Techne 5:50 a.m. July 8, 2014 - PR Newswire - PRF
Biotechnology Equities Movers and Shakers -- Research on ZIOPHARM Oncology, Clovis Oncology, Arrowhead Research, and NPS Pharma 7:50 a.m. June 27, 2014 - PR Newswire - PRF
Clinical Studies, Trials Results, Appointments, and Technical Updates - Analyst Notes on Ohr, Ariad, Arrowhead, CytRx and Karyopharm Therapeutics 5:00 a.m. June 27, 2014 - PR Newswire - PRF
Upcoming Conferences, Tentative Meeting Schedules, Analyst Day, Public Offerings, and Data Presentations - Analyst Notes on Incyte, NPS Pharmaceuticals, Arrowhead, Novavax and Chelsea Therapeutics 5:00 a.m. June 17, 2014 - PR Newswire - PRF
Arrowhead Research Set to Join Russell 3000 Index 7:30 a.m. June 16, 2014 - BusinessWire - BZX
Arrowhead Issues a Statement on Intellectual Property Protection for ARC-520 5:41 p.m. June 13, 2014 - BusinessWire - BZX
Arrowhead to Host Analyst Day to Discuss New Rare Liver Disease Candidate 4:05 p.m. June 11, 2014 - BusinessWire - BZX
Arrowhead to Present at Upcoming Investor Conferences 4:05 p.m. June 10, 2014 - BusinessWire - BZX
Strategic Acquisitions, Clinical Data Presentations, Research Grants, and Technical Updates - Analyst Notes on Acadia, Opko Health, Arrowhead Research, Agios Pharmaceuticals and Sangamo Biosciences 5:10 a.m. June 6, 2014 - PR Newswire - PRF
Arrowhead to Present at the Jefferies 2014 Global Healthcare Conference 7:31 a.m. May 29, 2014 - BusinessWire - BZX
Top Gainers Pre-Market Notes -- Research on Millennial Media, Demandware, Arrowhead Research, and KEYW Holding 9:12 a.m. May 20, 2014 - PR Newswire - PRF
Earnings Release Results, and Leadership Appointments - Analyst Notes on Halozyme, MannKind, Arrowhead, Idera and BioCryst 7:00 a.m. May 16, 2014 - PR Newswire - PRF
Arrowhead to Present at Upcoming Scientific Conferences 4:04 p.m. May 6, 2014 - BusinessWire - BZX
Arrowhead Reports Fiscal 2014 Second Quarter Financial Results 4:03 p.m. May 6, 2014 - BusinessWire - BZX
Arrowhead to Present at Deutsche Bank 39th Annual Health Care Conference 7:32 a.m. May 1, 2014 - BusinessWire - BZX
Arrowhead to Report Fiscal 2014 Second Quarter Financial Results 4:08 p.m. April 29, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼
